CPRX CATALYST PHARMACEUTICALS, INC.: institutional ownership and insider trading
359 funds reported holding $3.64B of CATALYST PHARMACEUTICALS, INC. in their latest 13F filings; in Q2 2026 funds net bought $90.8M, with 96 new positions and 82 funds selling out; over the last 12 months insiders bought $0 and sold $1.79M on the open market.
Famous investors holding CPRX
- George Soros (Soros Fund Management): $10.8M, 0.1% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $67.1M, 0.1% of the portfolio
- Izzy Englander (Millennium Management): $33.6M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $4.23M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $3.04M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $954K, 0.0% of the portfolio
Largest institutional holders of CPRX
- BlackRock, Inc. (BLK) — $602M
- STATE STREET CORP (STT, STT-PG) — $240M
- VANGUARD GROUP INC — $197M
- AMERICAN CENTURY COMPANIES INC — $175M
- VANGUARD CAPITAL MANAGEMENT LLC — $161M
- DIMENSIONAL FUND ADVISORS LP — $114M
- GLAZER CAPITAL, LLC — $113M
- JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) — $99.9M
- GEODE CAPITAL MANAGEMENT, LLC — $99.0M
- HBK INVESTMENTS L P — $88.6M
Recent CPRX insider trades
- Dec 12, 2025: Harper Molly sold 26,746 shares ($622K)
- Nov 26, 2025: Del Carmen Jeffrey sold 10,983 shares ($256K)
- Nov 12, 2025: Elsbernd Brian sold 40,000 shares ($908K)
- Sep 8, 2025: Elsbernd Brian sold 30,000 shares ($609K)
5%+ owners
- BlackRock, Inc.: 13.9% (Schedule 13G/A, filed Apr 28, 2025)
- STATE STREET CORPORATION: 5.2% (Schedule 13G, filed Nov 10, 2025)